Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections
1988

Study of Tumor-Associated Protease Activity

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): F.S. Steven, M.M. Griffin, H. Maier, H. Weidauer, W.F. Mangel, M. Altmannsberger

Primary Institution: University of Manchester

Hypothesis

The activity of guanidinobenzoatase at the advancing edge of tumor masses is controlled by a naturally occurring inhibitor.

Conclusion

The study suggests that uninhibited guanidinobenzoatase at the tumor's leading edge may play a significant role in tissue invasion.

Supporting Evidence

  • The study found that tumor cells at the advancing edge had uninhibited guanidinobenzoatase.
  • Formaldehyde treatment revealed latent enzyme activity in frozen sections.
  • A synthetic inhibitor of guanidinobenzoatase selectively inhibited the enzyme in tumor cells.
  • Fluorescent microscopy allowed for the visualization of enzyme activity in tumor sections.

Takeaway

This study looked at a special enzyme in tumor cells that helps them invade other tissues, and found that blocking this enzyme could help control tumor growth.

Methodology

Fluorescent microscopy was used to analyze frozen sections of human tumors, focusing on the activity of guanidinobenzoatase.

Potential Biases

The study was conducted in ignorance of previous pathological analyses, which could introduce bias.

Limitations

The analysis was conducted without prior training in histology or pathology, which may affect the interpretation of results.

Participant Demographics

Frozen sections were obtained from 55 subjects with tumors from the head and neck region.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication